{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:48:26Z","timestamp":1790873306642,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Purpose<\/jats:title>\n<jats:p>Highlight and characterize manifestations, diagnostic\/management approaches and outcomes in a contemporary cohort of patients with pituitary metastases (PM) from a large European pituitary center\u2014over 10\u00a0years.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Retrospective review of PM cases between 1\/2009 and 12\/2018. Clinical, laboratory, imaging data at PM detection and during follow-up were analysed.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>18 cases were identified (14 females; median age at diagnosis 61.5\u00a0years). Most common primary malignancies were lung (39%) and breast (32%). Most frequent presenting manifestation was visual dysfunction (50%). Gonadotrophin, ACTH, TSH deficiency were diagnosed in 85%, 67%, 46% of cases, respectively; diabetes insipidus (DI) was present in 17%. 33% of cases were detected during investigation for symptoms unrelated to PM. PM management included radiotherapy (44%), transsphenoidal surgery (17%), transsphenoidal surgery and radiotherapy (6%) or monitoring only (33%). One-year survival was 49% with median survival from PM detection 11\u00a0months (range 2\u201347).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>In our contemporary series, clinical presentation of PM has evolved; we found increased prevalence of anterior hypopituitarism, decreased rates of DI and longer survival compared with older literature. Increased availability of diagnostic imaging, improvements in screening and recognition of pituitary disease and longer survival of patients with metastatic cancer may be contributing factors.<\/jats:p>\n<\/jats:sec>","DOI":"10.1007\/s11102-020-01034-2","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T11:56:39Z","timestamp":1584532599000},"page":"258-265","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Pituitary metastases: presentation and outcomes from a pituitary center over the last decade"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3140-6957","authenticated-orcid":false,"given":"K.","family":"Lithgow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Siqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Senthil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. S.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. V.","family":"Chavda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ayuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Toogood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Gittoes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Meade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sanghera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Paluzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Tsermoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4696-0643","authenticated-orcid":false,"given":"N.","family":"Karavitaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,18]]},"reference":[{"issue":"2","key":"1034_CR1","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1210\/jc.2003-030395","volume":"89","author":"J Komninos","year":"2004","unstructured":"Komninos J, Vlassopoulou V, Protopapa D, Korfias S, Kontogeorgos G, Sakas DE, Thalassinos NC (2004) Tumors metastatic to the pituitary gland: case report and literature review. J Clin Endocrinol Metab 89(2):574\u2013580. https:\/\/doi.org\/10.1210\/jc.2003-030395","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1034_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11102-014-0552-2","volume":"18","author":"W He","year":"2015","unstructured":"He W, Chen F, Dalm B, Kirby PA, Greenlee JD (2015) Metastatic involvement of the pituitary gland: a systematic review with pooled individual patient data analysis. Pituitary 18(1):159\u2013168. https:\/\/doi.org\/10.1007\/s11102-014-0552-2","journal-title":"Pituitary"},{"issue":"6","key":"1034_CR3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s11102-013-0542-9","volume":"17","author":"R Al-Aridi","year":"2014","unstructured":"Al-Aridi R, El Sibai K, Fu P, Khan M, Selman WR, Arafah BM (2014) Clinical and biochemical characteristic features of metastatic cancer to the sella turcica: an analytical review. Pituitary 17(6):575\u2013587. https:\/\/doi.org\/10.1007\/s11102-013-0542-9","journal-title":"Pituitary"},{"issue":"5","key":"1034_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s11102-018-0899-x","volume":"21","author":"M Castle-Kirszbaum","year":"2018","unstructured":"Castle-Kirszbaum M, Goldschlager T, Ho B, Wang YY, King J (2018) Twelve cases of pituitary metastasis: a case series and review of the literature. Pituitary 21(5):463\u2013473. https:\/\/doi.org\/10.1007\/s11102-018-0899-x","journal-title":"Pituitary"},{"key":"1034_CR5","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0338","author":"A Javanbakht","year":"2018","unstructured":"Javanbakht A, D'Apuzzo M, Badie B, Salehian B (2018) Pituitary metastasis: a rare condition. Endocr Connect. https:\/\/doi.org\/10.1530\/EC-18-0338","journal-title":"Endocr Connect"},{"issue":"6","key":"1034_CR6","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1210\/jc.2011-0168","volume":"96","author":"P Famini","year":"2011","unstructured":"Famini P, Maya MM, Melmed S (2011) Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients. J Clin Endocrinol Metab 96(6):1633\u20131641. https:\/\/doi.org\/10.1210\/jc.2011-0168","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1034_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.wneu.2012.03.018","volume":"79","author":"M Zoli","year":"2013","unstructured":"Zoli M, Mazzatenta D, Faustini-Fustini M, Pasquini E, Frank G (2013) Pituitary metastases: role of surgery. World Neurosurg 79(2):327\u2013330. https:\/\/doi.org\/10.1016\/j.wneu.2012.03.018","journal-title":"World Neurosurg"},{"issue":"1","key":"1034_CR8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/1097-0142(197507)36:1%3c216::aid-cncr2820360123%3e3.0.co;2-e","volume":"36","author":"RJ Teears","year":"1975","unstructured":"Teears RJ, Silverman EM (1975) Clinicopathologic review of 88 cases of carcinoma metastatic to the putuitary gland. Cancer 36(1):216\u2013220. https:\/\/doi.org\/10.1002\/1097-0142(197507)36:1%3c216:aid-cncr2820360123%3e3.0.co;2-e","journal-title":"Cancer"},{"issue":"8","key":"1034_CR9","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1210\/jc.2019-00012","volume":"104","author":"F Schill","year":"2019","unstructured":"Schill F, Nilsson M, Olsson DS, Ragnarsson O, Berinder K, Ed\u00e9n Engstr\u00f6m B, Dahlqvist P, Wahlberg J, Englund E, Burman P (2019) Pituitary metastases: a nationwide study on current characteristics with special reference to breast cancer. J Clin Endocrinol Metab 104(8):3379\u20133388. https:\/\/doi.org\/10.1210\/jc.2019-00012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1034_CR10","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.surneu.2008.06.003","volume":"72","author":"H Kano","year":"2009","unstructured":"Kano H, Niranjan A, Kondziolka D, Flickinger JC, Lunsford LD (2009) Stereotactic radiosurgery for pituitary metastases. Surg Neurol 72(3):248\u2013255. https:\/\/doi.org\/10.1016\/j.surneu.2008.06.003","journal-title":"Surg Neurol"},{"issue":"Suppl","key":"1034_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3171\/sup.2006.105.7.37","volume":"105","author":"Y Mori","year":"2006","unstructured":"Mori Y, Kobayashi T, Shibamoto Y (2006) Stereotactic radiosurgery for metastatic tumors in the pituitary gland and the cavernous sinus. J Neurosurg 105(Suppl):37\u201342. https:\/\/doi.org\/10.3171\/sup.2006.105.7.37","journal-title":"J Neurosurg"},{"key":"1034_CR12","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.wneu.2017.06.139","volume":"106","author":"CR Goulart","year":"2017","unstructured":"Goulart CR, Upadhyay S, Ditzel Filho LFS, Beer-Furlan A, Carrau RL, Prevedello LM, Prevedello DM (2017) Newly diagnosed sellar tumors in patients with cancer: a diagnostic challenge and management dilemma. World Neurosurg 106:254\u2013265. https:\/\/doi.org\/10.1016\/j.wneu.2017.06.139","journal-title":"World Neurosurg"},{"issue":"1","key":"1034_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11102-015-0676-z","volume":"19","author":"T Burkhardt","year":"2016","unstructured":"Burkhardt T, Henze M, Kluth LA, Westphal M, Schmidt NO, Flitsch J (2016) Surgical management of pituitary metastases. Pituitary 19(1):11\u201318. https:\/\/doi.org\/10.1007\/s11102-015-0676-z","journal-title":"Pituitary"},{"issue":"3","key":"1034_CR14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1210\/jcem-65-3-469","volume":"65","author":"CL Branch Jr","year":"1987","unstructured":"Branch CL Jr, Laws ER Jr (1987) Metastatic tumors of the sella turcica masquerading as primary pituitary tumors. J Clin Endocrinol Metab 65(3):469\u2013474. https:\/\/doi.org\/10.1210\/jcem-65-3-469","journal-title":"J Clin Endocrinol Metab"},{"issue":"33","key":"1034_CR15","doi-asserted-by":"publisher","first-page":"55544","DOI":"10.18632\/oncotarget.15417","volume":"8","author":"H Ju","year":"2017","unstructured":"Ju H, Zhou J, Pan Y, Lv J, Zhang Y (2017) Evaluation of pituitary uptake incidentally identified on (18)F-FDG PET\/CT scan. Oncotarget 8(33):55544\u201355549. https:\/\/doi.org\/10.18632\/oncotarget.15417","journal-title":"Oncotarget"},{"issue":"3","key":"1034_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.2176\/nmc.44.112","volume":"44","author":"Y Iwai","year":"2004","unstructured":"Iwai Y, Yamanaka K, Honda Y, Matsusaka Y (2004) Radiosurgery for pituitary metastases. Neurol Med Chir (Tokyo) 44(3):112\u2013116. https:\/\/doi.org\/10.2176\/nmc.44.112","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"8","key":"1034_CR17","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1093\/neuonc\/nor055","volume":"13","author":"H Iwata","year":"2011","unstructured":"Iwata H, Sato K, Tatewaki K, Yokota N, Inoue M, Baba Y, Shibamoto Y (2011) Hypofractionated stereotactic radiotherapy with CyberKnife for nonfunctioning pituitary adenoma: high local control with low toxicity. Neuro-Oncology 13(8):916\u2013922. https:\/\/doi.org\/10.1093\/neuonc\/nor055","journal-title":"Neuro-Oncology"},{"issue":"1","key":"1034_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11060-016-2346-z","volume":"132","author":"H Chon","year":"2017","unstructured":"Chon H, Yoon K, Kwon DH, Kim CJ, Kim MS, Cho YH (2017) Hypofractionated stereotactic radiosurgery for pituitary metastases. J Neurooncol 132(1):127\u2013133. https:\/\/doi.org\/10.1007\/s11060-016-2346-z","journal-title":"J Neurooncol"},{"issue":"29","key":"1034_CR19","first-page":"1567","volume":"28","author":"MP Ntyonga-Pono","year":"1999","unstructured":"Ntyonga-Pono MP, Thomopoulos P, Luton JP (1999) Pituitary metastases. 3 cases. Presse Med 28(29):1567\u20131571","journal-title":"Presse Med"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-020-01034-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-020-01034-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-020-01034-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:27:47Z","timestamp":1616027267000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-020-01034-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,18]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1034"],"URL":"https:\/\/doi.org\/10.1007\/s11102-020-01034-2","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,18]]},"assertion":[{"value":"18 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}